FdaApplication
BLA 208471
Identifiers
- fda_app_no: BLA208471
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi-Aventis U.S. LLC |
| application_type | BLA |
| approval_date | 2016-07-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ADLYXIN | LIXISENATIDE | 300MCG/3ML (100MCG/ML) | Injection |
| ADLYXIN | LIXISENATIDE | 150MCG/3ML (50MCG/ML) | Injection |
2 products